The use of newly marketed drugs in child
โ
Lynda V. Wilton; Gillian Pearce; Ronald D. Mann
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 111 KB
๐ 2 views
This study determined the licensed and `o label' (outside the terms of the licence) use of newly marketed medicines in children (2ยฑ11 years) and adolescents (12ยฑ17 years), by general practitioners in England. In addition, the incidence rates during the ยฎrst month of therapy (ID 1 ) for three adverse